05/07/2026
Did you know that Medicare will offer coverage for specific FDA-approved weight loss drugs such as Wegovy and Zepbound through a $50 co-pay program?
The "GLP-1 Bridge" program, which starts July 1, 2026 allows beneficiaries with obesity-related conditions to cover certain medications used for weight loss. Currently Medicare does covers these medications for Type 2 diabetes, or cardiovascular risk reduction.
Medications are Wegovy and select Zepbound formulations other than the single dose pens. And coverage is for people with a BMI of 35 or higher, or a BMI of 27-34 with other clinical criteria.
Covers Wegovy and select Zepbound formulations (not the single-dose pens) for people with a BMI of 35 or higher, or a BMI of 27-34 with other clinical criteria.
Additional details to come......
If you have questions or concerns about Medicare, we can help. Message us directly for your free consultation.